Settlement of the CR is likely to occur today according to the announcement. Therefore the recent selling could well be attributed to existing holders raise fund and re-balance their portfolios for the settlement. The drop in SP seems logical and normal.
The EFS trial is about to start this month. If the recruitment goes well and the results are good, our competitors could be very worried as each recruited patient could translate to not just the lost revenue to them now but well into the future potentially.
Not advice, DYOR
Ann: $35M Capital Raise, page-139
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
-0.300(1.73%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| $17.00 | $17.44 | $16.95 | $184.6K | 10.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $17.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.50 | 500 | 1 |
View Market Depth
| Last trade - 15.59pm 19/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |